The main risk associated with the failure of the trials is a “potential loss of confidence” in the company, according to Jefferies: based on their information, AstraZeneca’s management was confident in the effectiveness of the drug’s development / Photo: Declan Sun / unsplash
News·
AstraZeneca lost $27 billion in market capitalization in a single day: its drug failed clinical trials
PepsiCo reported its second-quarter 2026 results / Photo: Shutterstock.com / LCV
News·
PepsiCo warned of "rising inflationary pressures" for U.S. consumers
Photo: X / NYSE
News·
Chipmakers Offset Tensions in the Middle East: U.S. Stocks Rise
The iconic Porsche 911 sports car has been in production since 1964 / Photo: Just dance/Shutterstock.com
News·
Porsche sales have fallen to a six-year low. But demand for the iconic model has risen
News·
A Forbes billionaire outlined five scenarios for postwar Russia
News·
The Korean stock market is no longer the most efficient in the world. Which market has surpassed it?
News·
Traffic in the Strait of Hormuz has virtually come to a standstill. This will hinder the resumption of oil shipments
Small Caps·
Wall Street sees 50% upside for pet supplies retailer Chewy. What's in the valuation?
Stock Screener
Buy
Sell
Go to section
Guru Portfolios

Track the investments of top funds and market legends

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Go to section
Small Caps
Since the markets last low on April 8, 2025, the Russell 2000 has gained 74.5%, while the Russell Microcap is up 108.4% / Photo: Facebook / NYSE
Small Caps·
Royce: Small and micro caps outperform in 2Q26; leadership likely to continue
Small Caps·
A fund involving Trump sons made hundreds of millions from micro-cap trades
Small Caps·
Small caps last week: Russell 2000 outperforms, Freedom 2H optimism, AeroVironment up
Small Caps·
Freedom Broker: S&P SmallCap 600 set to double growth of S&P 500 in 2H26
Small Caps·
How Interparfums built a fragrance empire on luxury brand licenses
Go to section

Investment and Finance News